A former co-founder and CTO, he helps shape the company’s AI direction, focusing on clinical trial modernization, patient recruitment, and AI-powered identification and site selection. His bylines and perspectives indicate a strong interest in using data-first approaches to reduce trial friction and accelerate enrollment, making it faster, more inclusive, and more reliable.
